Literature DB >> 6499771

Absence of biological effects of oxidized parathyroid hormone-(1-34) in dogs and rats.

T Galceran, J Lewis-Finch, K J Martin, E Slatopolsky.   

Abstract

Recent studies have shown that oxidation of bovine PTH-(1-34) [bPTH-(1-34)] with H2O2 abolished the vascular effects of PTH in rats and dogs, but the hypercalcemic effect of the oxidized PTH was preserved in the Japanese quail in vivo. These observations seem at variance with previous studies from our laboratory in the isolated perfused canine tibia preparation in which no uptake of immunoreactive PTH or stimulation of cAMP release was demonstrated during infusion of oxidized bPTH-(1-34). The present studies examine the skeletal and renal effects of oxidized PTH-(1-34) in rats and dogs in vivo. Oxidation of PTH with H2O2 reduced its activation of adenylate cyclase by 95% in dog renal cortical membrane. Awake normal dogs were studied before and during the infusion of bPTH-(1-34) or oxidized PTH-(1-34) (4 U/kg X h). With active PTH, ionized Ca+2 rose in each dog (range, 0.7-1.5 mg/dl), while with oxidized PTH, Ca+2 remained within 0.1 mg/dl of the baseline values. Fractional excretion of PO4 rose from 1.58 +/- 0.6% to 29.5 +/- 2.5% with active PTH and from 1.4 +/- 0.4% to 5.7 +/- 1% with oxidized PTH. The latter did not differ from the value in vehicle-infused dogs. Further studies were performed in 30 acutely parathyroidectomized rats. Plasma Ca+2 rose from 8.2 +/- 0.1 to 9.0 +/- 0.3 mg/dl with active PTH (20 micrograms/kg), fell to 7.7 +/- 0.2 with oxidized PTH, and fell to 7.3 +/- 0.3 mg/dl with vehicle. In parathyroid-intact rats plasma Ca+2 increased by 0.9 mg/dl whether given active PTH, oxidized PTH, or vehicle. We conclude that oxidation of bPTH-(1-34) results in loss of both the renal and skeletal effects of PTH in vivo in rats and dogs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6499771     DOI: 10.1210/endo-115-6-2375

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Oxidation inhibits PTH receptor signaling and trafficking.

Authors:  Juan A Ardura; Verónica Alonso; Pedro Esbrit; Peter A Friedman
Journal:  Biochem Biophys Res Commun       Date:  2016-11-28       Impact factor: 3.575

2.  Bone mass and biomarkers in young women with anorexia nervosa: a prospective 3-year follow-up study.

Authors:  Anna Svedlund; Cecilia Pettersson; Bojan Tubic; Lars Ellegård; Anders Elfvin; Per Magnusson; Diana Swolin-Eide
Journal:  J Bone Miner Metab       Date:  2022-08-12       Impact factor: 2.976

Review 3.  Hope for CKD-MBD Patients: New Diagnostic Approaches for Better Treatment of CKD-MBD.

Authors:  Berthold Hocher; Andreas Pasch
Journal:  Kidney Dis (Basel)       Date:  2017-06-16

4.  The effect of vitamin D supplementation on plasma non-oxidised PTH in a randomised clinical trial.

Authors:  Stan Ursem; Vito Francic; Martin Keppel; Verena Schwetz; Christian Trummer; Marlene Pandis; Felix Aberer; Martin R Grübler; Nicolas D Verheyen; Winfried März; Andreas Tomaschitz; Stefan Pilz; Barbara Obermayer-Pietsch; Annemieke C Heijboer
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

Review 5.  Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications.

Authors:  Kittrawee Kritmetapak; Chatlert Pongchaiyakul
Journal:  Int J Nephrol       Date:  2019-09-17

6.  Measuring parathyroid hormone (PTH) in patients with oxidative stress--do we need a fourth generation parathyroid hormone assay?

Authors:  Berthold Hocher; Franz Paul Armbruster; Stanka Stoeva; Christoph Reichetzeder; Hans Jürgen Grön; Ina Lieker; Dmytro Khadzhynov; Torsten Slowinski; Heinz Jürgen Roth
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.